Discover 1,944 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,944
Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy
for
Generalized Lipodystrophy
Location: Dallas TX, Ann Arbor MI
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 2+
Code: NCT07220785
Phase 3, Recruiting
Late Onset Alzheimer's Disease
for
Alzheimer Disease
Location: Dallas TX, St Louis MO, Bloomington IN, Indianapolis IN,
Sponsor: Columbia University
Sex: All
Age: 55+
Code: NCT05010603
Recruiting
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
for
Acute Leukemia
Location: Dallas TX, Houston TX, San Antonio TX, Albuquerque NM,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 2+
Code: NCT04811560
Phase 1, Phase 2, Recruiting
Pegtibatinase as a Treatment for Participants With Classical Homocystinuria (HCU) Receiving Standard of Care Treatment
for
Homocystinuria
Location: Dallas TX, Atlanta GA, Chicago IL, Phoenix AZ,
Sponsor: Travere Therapeutics, Inc.
Sex: All
Age: 12 - 65
Code: NCT06247085
Phase 3, Recruiting
Product Surveillance Registry
for
Cardiac Rhythm Disorders, Urological Disorders,
Location: Fort Worth TX, Grapevine TX, Dallas TX, Plano TX,
Sponsor: Medtronic
Sex: All
Age: 0+
Code: NCT01524276
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Natural History Study of Participants With Sanfilippo Syndrome Type IIIC
for
Sanfilippo Syndrome Type C
Location: Dallas TX
Sponsor: Phoenix Nest
Sex: All
Age: 1+
Code: NCT05825131
Recruiting
APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
Location: Dallas TX, Houston TX, Milwaukee WI, Phoenix AZ,
Sponsor: TransMedics
Sex: All
Age: 0+
Code: NCT06513091
Recruiting
Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
for
Phenylketonuria
Location: Dallas TX, Aurora CO, Indianapolis IN, Chicago IL,
Sponsor: BioMarin Pharmaceutical
Sex: All
Age: 18 - 65
Code: NCT07477691
Phase 4, Recruiting
Prospective Investigation of Cirrhotic Cardiomyopathy in Humans
for
Cirrhotic Cardiomyopathy
Location: Dallas TX, Nashville TN
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 18+
Code: NCT07658222
Recruiting
A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
for
Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma,
Location: Dallas TX, Wichita KS, Nashville TN, Iowa City IA,
Sponsor: TORL Biotherapeutics, LLC
Sex: All
Age: 18+
Code: NCT07439653
Phase 1, Phase 2, Recruiting
DALY II USA/ MB-CART2019.1 for DLBCL
for
Refractory Diffuse Large B Cell Lymphoma (DLBCL),
Location: Dallas TX, Houston TX, San Antonio TX, Westwood KS,
Sponsor: Miltenyi Biomedicine GmbH
Sex: All
Age: 18+
Code: NCT04792489
Phase 2, Recruiting
A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant
for
Renal Transplant Failure and Rejection
Location: Dallas TX, Metairie LA, Kansas City KS, Atlanta GA,
Sponsor: ITB-Med LLC
Sex: All
Age: 18 - 70
Code: NCT07508787
Phase 2, Recruiting
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
for
Pulmonary Arterial Hypertension
Location: Dallas TX, Houston TX, San Antonio TX, Kansas City KS,
Sponsor: Gossamer Bio USA, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06274801
Phase 3, Recruiting
Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
for
Open Angle Glaucoma (OAG)
Location: Dallas TX, Houston TX, Grand Junction CO, Kenosha WI,
Sponsor: Avisi Technologies Inc.
Sex: All
Age: 45+
Code: NCT07220876
Recruiting
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
for
SLE, SLE (Systemic Lupus)
Location: Plano TX, Webster TX, Memphis TN, Iowa City IA,
Sponsor: Cullinan Therapeutics Inc.
Sex: All
Age: 18 - 70
Code: NCT06613360
Phase 1, Recruiting
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer
for
Triple Negative Breast Cancer
Location: Dallas TX, Germantown TN, Westwood KS, St Louis MO,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT06926920
Phase 1, Phase 2, Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease